Загрузка...
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine
The Coronavirus Disease 2019 (COVID-19) pandemic caused by the Severe Acute Respiratory Syndrome Related Coronavirus 2 (SARS-CoV-2) is a global health emergency. As only very limited therapeutic options are clinically available, there is an urgent need for the rapid development of safe, effective, a...
Сохранить в:
| Опубликовано в: : | Emerg Microbes Infect |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7594754/ https://ncbi.nlm.nih.gov/pubmed/32975484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/22221751.2020.1829082 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|